Conversely, reducing IRF4 expression can lead to increased IRF5 expression, promote M1-type activation, exacerbate the inflammatory response, and lead to worse outcomes in cerebral ischemia (Al Mamun et al., 2020). The gene discussed is IRF5; the disease is brain ischemia.